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3D hydrogel mimics of the tumor
microenvironment: the interplay among
hyaluronic acid, stem cells and cancer cells†
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The present work reports on a 3D model of the tumor microenvironment that contains hyaluronic acid
(HA) and alginate, and demonstrates the utility of this model to study the effect of HA size on the crosstalk
between cancer cells and mesenchymal stem cells (MSCs). The system incorporates a core that contains
HA of specific size (i.e. 6.4, 741 or 1500 kDa) with encapsulated epithelial MKN45 cancer cells and a shell
with MSCs that mimic the presence of stem cells next to the tumor site. It was found that short HA (i.e.
6.4 kDa) promotes the invasion of cancer cells from the core to the shell, whereas longer HA (i.e. 741 and
1500 kDa) recruits the MSCs into the core, i.e. the tumor site, where a reduction of the formation of
cancer cell aggregates was observed. In summary, the developed 3D model recapitulates some key tumor
features related to the effect of HA size on both cancer cell invasiveness and MSC behavior at the
tumor site.
Introduction
The interactions of cancer cells (CCs) with the components of
the surrounding microenvironment, such as proteins, glyco-
proteins, proteoglycans, signaling molecules and different cell
types, create a complex tumor microenvironment (TME).1–3
Changes in the TME impact cancer progression: unbalanced
synthesis and degradation of its components lead to altered
stiffness, elasticity, permeability,4 and biochemical
composition.5,6 One of the TME components that plays a critical
role in cancer invasiveness is hyaluronic acid (HA).7,8 The
abnormal synthesis of HA by the synthases and the deregulated
digestion by hyaluronidases lead to the accumulation of HA
with different molecular weights (Mws) in the basement mem-
brane of cancer cells.7 The accumulated HA can trigger various
signaling pathways (e.g. via interaction with HA-specific trans-
membrane receptor CD44) that affect cell proliferation,
migration or even latency and apoptosis.6 The cell response is
dependent on the Mw of HA:
9,10 low Mw HA (<100 kDa) is pro-
inflammatory and promotes CC invasion and metastasis, while
high Mw (>1000 kDa) HA induces CC latency.
7,11 The TME is
also governed by the crosstalk between CCs and healthy cells
from the surrounding microenvironment (e.g. mesenchymal
stem cells – MSCs, macrophages and fibroblasts, among
others).12–14 MSCs are linked to tumor progression but their
role is controversial. Some authors show that MSCs induce
tumor growth by disrupting cell-to-cell contact and promoting
CC invasion.15 Other works suggest that MSCs inhibit the inva-
siveness of CCs by reducing their drug resistance.16 In fact, the
MSCs’ activity depends on their density. It has been reported
that a 1 : 1 MSC : CC ratio induces upregulation of metastatic
genes; whereas a lower ratio (e.g. 1 : 2) results in tumor
remission.17–19 The presence of MSCs can also influence the CC
aggregation: the MSCs added to pre-formed aggregates caused
disorganization of the structures, while the MSCs present since
the beginning of the formation of CC spheroids enhanced
spatial organization and homogeneity.20
The complexity of the TME as well as the mismatch
between different animal models and the human cellular
environment impose the development of 3D models that
mimic the biochemical and mechanical features of the TME as
a valuable tool to study cancer progression and/or the
efficiency of different treatments.21,22 Herein, we developed a
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3D co-culture system that recapitulates some important fea-
tures of the TME: the core is the cancer site with encapsulated
CCs exposed to HA of specific Mws that are known to elicit
different CC responses, e.g. migration or latency, and the sur-
rounding shell contains healthy MSCs that can crosstalk with
the CCs present at the cancer site (i.e. core of the hydrogel).
We demonstrate that this system can replicate the key features
of cancer progression and invasiveness.
Materials and methods
Materials
Sodium hyaluronates (HA) with Mws of 6.4, 741 and 1500 kDa
were acquired from Lifecore (USA) and sodium alginate (Alg,
UP VLVG, >75 kDa) from Pronova (Norway). The
CD44 monoclonal antibody (Ascites, AM06286SU-N) was pur-
chased from ACRIS. The FITC-labelled CD90 (Thy-1) mono-
clonal antibody (eBio5E10 (5E10)) was obtained from
eBioscience™. The other antibodies, rabbit monoclonal to
Vimentin [EPR3776], rabbit monoclonal to E-cadherin
[EP700Y] and rabbit monoclonal to alpha smooth muscle actin
[E184], were obtained from Abcam. The secondary antibodies
IRDye® 800CW Goat-anti-Rabbit and IRDye® 800CW Goat-
anti-Mouse were obtained from LI-COR Biosciences.
Methods
Hyaluronic acid modification with FITC. Fluoresceinamine
(FITC) was coupled to the carboxylic groups of HA of different
Mws (i.e. 6.4, 741 and 1500 kDa) using N-(3-dimethyl-
aminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC)
chemistry as previously described.23
Preparation of hydrogels. Alg and HA were dissolved in
Milli-Q water and NaCl 0.15 M, respectively. Both solutions
were mixed to a final concentration of 20 mg mL−1 of Alg and
1 mg mL−1 of HA. Spheres (core of the 3D system) were
extruded (27G syringe) into a CaCl2 solution (100 mM) under
constant magnetic stirring. After gelation, the spheres were
washed with Tris-buffered saline (TBS) supplemented with
15 mM CaCl2. The Alg or Alg-HAMw spheres were embedded
in a pre-gelated Alg disc and the core–shell hydrogels were
allowed to crosslink on a QGel® mould immersed in 50 mM
CaCl2 for 15 min. The final construct was washed with
TBS-CaCl2.
Culture, expansion and seeding of a gastric cancer cell line
and bone marrow mesenchymal stem cells. The human
gastric cancer cell line MKN45 (passages 6 or 7) was cultured
in RPMI-1640 medium (Sigma-Aldrich, Portugal) sup-
plemented with 10% fetal bovine serum (FBS; Gibco) and 1%
antibiotic/antimycotic solution (final concentration of peni-
cillin: 100 units per mL, streptomycin: 100 mg mL−1 and
25 μg mL−1 amphotericin B; Gibco, UK). Human bone
marrow aspirates were collected from patients subjected to
total hip replacement surgery, under the scope of an agree-
ment (Ref. DC 05/2015) with Hospital da Prelada (Porto,
Portugal). Bone marrow mesenchymal stem cells (bmMSCs)
were isolated from the tissue according to a previously pub-
lished procedure.24 Afterwards, bmMSCs were expanded in
Minimum Essential Medium (MEM) alpha medium (αMEM;
Sigma-Aldrich, Germany) supplemented with 1% antibiotic/
antimycotic (Gibco) and 10% FBS and used at passage 3. Both
cell types, MKN45 and bmMSCs, were cultured in a 5% CO2
incubator maintained at 37 °C. For the encapsulation of cells
into the hydrogel, MKN45 and bmMSCs were washed with PBS
and harvested with TrypLE™ Express. MKN45 cells (at a cell
density of 5 × 106 cells per mL) were dispersed in Alg or Alg-
HAMw solution and extruded as described above (i.e. 47 μL per
sphere volume). The spheres with the cells were further
embedded in an Alg disc (70 μL shell disc) containing
bmMSCs (2 × 106 cells per mL) that were previously encapsu-
lated during processing and expanded in αMEM for 3 days.
The core–shell system was incubated for 10 days in the pres-
ence of αMEM or with bmMSC-conditioned media (CM)
obtained from the expansion of stem cells for 3 days (1 : 1 ratio
of CM : fresh αMEM).
Cellular viability, morphology and distribution. To evaluate
the cellular viability after 10 days of culture, the cells were
stained with calcein-AM (1 μg mL−1 – green staining, live cells)
and propidium iodide (1 μL mL−1 – red staining, dead cells).
To assess the cellular distribution and expression of the
specific cellular markers for MKN45 and for bmMSCs (i.e.
CD44 and CD90, respectively), the hydrogels were washed with
TBS-CaCl2 and fixed with 16% formaldehyde (Pierce™,
P1304MP) for at least 1 h at room temperature under shaking.
After washing with TBS-CaCl2, the cells were permeabilized
with 0.1% Triton X-100 in TBS-CaCl2 for 15 min under stirring,
and blocked with 3% BSA in TBS-CaCl2 for 1 h at room temp-
erature. The CD44 and CD90 expression was evaluated using
the CD44 monoclonal antibody (1 : 350 in 1% w/v BSA/
TBS-CaCl2), followed by rabbit anti-mouse Alexa Fluor-594
(1 : 500 in 1% w/v BSA/TBS-CaCl2) and CD90-FITC (1 : 250 in
1% w/v BSA/TBS-CaCl2), respectively. Nuclei were counter-
stained with DAPI (1 mg mL−1 in 1% BSA in TBS-CaCl2). After
1 h of incubation with the antibodies, the gels were washed
with TBS-CaCl2 and observed under a confocal laser scanning
microscope (TCS SP8, Leica, Germany).
Cancer cell metabolic activity. The MKN45 viability on a
coculture hydrogel was determined using the Cell Titer 96®
Aqueous One Solution Cell Proliferation Assay (Promega, USA)
as described elsewhere.25 The MKN45 cell proliferation was
analysed using the total amount of double-stranded DNA after
10 days of culture. The core hydrogel was collected and placed
in 1 mL of ultrapure water and frozen at −80 °C, for thermal
shock. The supernatant was used for DNA quantification using
a Quant-iT PicoGreen® dsDNA Assay Kit (Invitrogen,
Molecular Probes, Oregon, USA), according to the manufac-
turer’s instructions.
Immunoblotting. Cell lysates were obtained from the
MKN45 cells extracted from the spheres of the core–shell
hydrogels. The total protein was extracted with radioimmuno-
precipitation assay using RIPA buffer (150 mM sodium chlor-
ide; 1% Triton-X100; 0.5% sodium deoxycholate; 0.1% sodium
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dodecyl sulphate; 50 mM Tris-Base – pH = 8) supplemented
with 1× protease (cOmplete™ ROCHE, Sigma-Aldrich,
Portugal) and 1× phosphatase (PhosSTOP™ ROCHE, Sigma-
Aldrich, Portugal) inhibitor cocktails. Briefly, the spheres were
carefully removed from the core–shell hydrogels and washed
with cold TBS-CaCl2. The protein lysates were extracted in RIPA
buffer for 30 min with 5 min intervals of vortexing. The
extracts were centrifuged (18 000g, 16 min, 4 °C), and the
supernatant was further analysed by western blotting (WB).
Each protein, under Laemmli buffer, was denatured at 37 °C
for 1 h 30 min and at 95 °C for 5 min prior to use. The lysates,
containing 20 μg of protein, were dissolved using 4–12% Bis-
Tris Protein Gels (Invitrogen NuPAGE, Thermo Fisher
Scientific, USA) and transferred to nitrocellulose membranes
(Thermo Fischer Scientific, USA). The membranes were incu-
bated in 4% (m/v) BSA in Tris-buffered saline-Tween (TBS-T,
Cell Signalling Technology) and probed with α-smooth muscle
actin (1 : 5000), Vimentin (1 : 1000) and E-cadherin (1 : 5000)
antibodies. After 3 cycles of 5 min washing with TBS-T, the
membranes were incubated with IRDye®800CW anti-Rabbit or
anti-Mouse (1 : 10 000) for 1 h and imaged on an Odyssey
Infrared Imaging System (LI-COR Biosciences, USA).
ELISA. The expression of IL-6 in the culture medium after 10
days of culture was evaluated by ELISA. The core–shell hydro-
gels containing MKN45-bmMSCs and the monoculture of
MKN45 were incubated in αMEM containing 10% FBS and 1%
antibiotic. After 10 days of culture, the medium was collected
and analysed using an IL-6 ELISA kit (R&D Systems Inc.,
Minneapolis, MN, USA), according to the manufacturer’s
instructions.
Mechanical properties. The cores of the hydrogels were ana-
lysed by Atomic Force Microscopy (AFM) using a JPK
NanoWizard 3 (JPK, Germany). The stiffness of Alg and Alg-
HAMw spheres was measured in TBS buffer, under QI
Advanced Mode using qp-BioAC-CB1 probes (resonance fre-
quency between 65 and 115 kHz; spring constant between 0.15
and 0.55 N m−1; NanoSensors, Germany). Prior to the experi-
ments, the probes were calibrated using the JPK non-contact
method. The Young’s modulus was calculated from fitting of
the approach curves with the Hertz/Sneddon model, using a
cone tip shape.
Image analysis. The volume (V) of the clusters was calculated
from the confocal laser scanning microscopy images, by
measuring the radius (r) of the cellular agglomerates according






π  r3 ð2Þ
where d1 and d2 are the length and width of the cells’ clusters,
respectively.
The quantification of fluorescence from the confocal
images and densitometric analysis of the WB membranes were
performed using ImageJ software (Version 2.0.0-rc-34/1.50a).
Statistical analysis. The normality of the data was analysed
using the Shapiro–Wilk test (p < 0.05). For the data that did
not follow a normal distribution, the Kruskal–Wallis test fol-
lowed by the Mann–Whitney test was used.
Results and discussion
Development of a core–shell 3D hydrogel
Mimicking the TME is challenging due to its complexity.13 Cell
spheroids and 3D scaffolds are the current in vitro TME
models used in cancer studies. Whereas spheroids are based
on clustering of one (e.g. CCs) or more cell types (e.g. cancer-
associated fibroblasts (CAFs) and MSCs), they lack the
dynamic crosstalk between CCs and the surrounding environ-
ment;26 the 3D hydrogel models mimic the features of the
extracellular matrix (ECM) composition by using specific com-
ponents of the ECM, with controlled porosity and mechanical
properties.27
Here, we developed a core–shell 3D cancer model that
resembles the complexity of the TME, combining (1) the pres-
ence of HA of different Mws in the ECM of the cancer tissue;
(2) its influence on the behaviour of gastric CCs (i.e. MKN45)
at the cancer site and of healthy bone marrow (bm) MSCs in
the neighbouring regions; and (3) the interplay among HA,
CCs and healthy bmMSCs (Fig. 1A).
The proposed system is composed of a core hydrogel’s
microparticle that contains HA of different Mws, blended with
the biocompatible Alg to generate the 3D polymer network
cross-linked under mild conditions, i.e. with Ca2+.28 We per-
formed an initial assessment of the stability of this system
and its ability to maintain the HA in the core of the 3D hydro-
gel. This was executed using labelled HA (i.e. HA-FITC)
making possible to confirm its incorporation into the core
of the construct (Fig. 1B) by fluorescence microscopy.
Fig. 1 (A) Graphical illustration of the developed 3D core–shell system
used for the co-culture of cancer MKN45 cells and bone marrow
mesenchymal stem cells (bmMSCs). Hydrogel images are shown in
Fig. S1.† (B) Confocal microscopy images showing the diffusion of the
HA (green) from the core to the shell (bottom images, where green
corresponds to HA-FITC incorporated in the Alg core; top images
merged channels from the transmitted and fluorescence images of the
Alg/HA-FITC).
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As expected, short HA (i.e. 6.4 kDa) is more diffusive: fluo-
rescence can be seen beyond the core of the system even at
very short immersion times. This diffusion can explain the
similarity between the mechanical properties and stability of
Alg and Alg-HA6.4 cores (Fig. 2A). However, in general, we
observe a reduction of stiffness when HA is combined with
Alg, with a higher impact as the HA’s Mw increases. HA con-
tributes differently to the stability of the hydrogels, with a
clear distinction between shorter HA chains (i.e. HA6.4) and
longer HA chains (i.e. HA741 and HA1500). Our results are con-
sistent with the ability of the longer chains of HA to partially
block the ionic crosslinking of Alg, leading to the formation
of hydrogels of lower stiffness (Fig. 2B2). In contrast, the
shorter chains of HA6.4 are not able to significantly block the
activity of the Ca2+ ions, presenting a limited impact on the
Alg cross-linking (Fig. 2B1).29,30 Another important point to
consider is the very high viscosity of HA1500 that strengthens
the Alg matrix, partially reverting the loss of stiffness
observed for the core composed of Alg-HA741.
After 7 days of immersion (5% CO2 incubator at 37 °C in
cell culture medium, but in the absence of cells), the Alg and
Alg-HA6.4 spheres lose their integrity due to the release of Ca
2+
(i.e. the Alg crosslinking agent) from the hydrogel network,
resulting in the disruption of the Alg matrix.31
Longer HA chains (i.e. 741 and 1500 kDa) remained
within the core even after 7 days of immersion (Fig. 1B) due
to the interpenetrating network formed by Alg and the
lower mobility and diffusion of the HA of high Mw com-
pared with those of the low Mw polymer. Overall, the gener-
ated Alg-HA741 and Alg-HA1500 networks had lower stiffness
values as compared to Alg (Fig. 2A); however they were more
stable after 7 days of immersion. In fact, their mechanical
properties did not change significantly over time, while the
Alg and Alg-HA6.4 disassembled during the same time
period.
The incorporation of MKN45 cells influences the mechanical
properties and stability of the hydrogels’ core
The stiffness of 3D matrices affects the cellular adhesion and
proliferation.32–35 In turn, cells also modulate the stiffness of
the surrounding environment through the secretion of
different proteins: the higher deposition of the ECM com-
ponents in the TME usually leads to a stiffening of the cancer
site.36
Indeed, we observed that the MKN45 cells encapsulated in
the construct’s core affected its mechanical properties (Fig. 3).
The MKN45 cells formed aggregates with increased cell viabi-
lity in the presence of HA (Fig. 4A – core). This result can be
explained with the recognition of HA by the MKN45 cells.37
Indeed, confocal microscopy showed a scattered fluorescence
signal indicating HA reorganization in the presence of cells
(Fig. 3A). At day 0, this change is visible only for the short and
diffusive HA6.4, i.e. immediately after cell encapsulation.
However, after 1 day of culture, similar redistribution is also
visible for the longer HA741 and HA1500. In these cases
(especially for HA1500), a blurred fluorescence co-exists with
the scattered signal suggesting the role of HA in two processes:
interpenetrating network formation (blurred fluorescence) and
cell–HA interactions.
Cellular encapsulation reduced the stiffness of the hydro-
gels (Fig. 2A vs. Fig. 3B, at day 0) but the dependence on the
HA size was similar to the one obtained for the hydrogels
without cells. The main difference was observed after 7 days
of culture: the MKN45 cells significantly improved the stabi-
lity of the Alg and Alg-HA6.4 hydrogels. These results are con-
sistent with the ability of the encapsulated cells to proliferate
and produce ECM under these experimental conditions
leading to improved stability of the 3D hydrogel structure
over time.38
Fig. 2 (A) Mechanical properties of the constructs’ cores incorporating
HA with different Mws (i.e. 6.4, 741 and 1500 kDa) as a function of
immersion time. (B) Schematic presentation of the molecular structure
of the cores made from Alg (black) and (B1) short or (B2) long HA chains
(blue) that results in the formation of an interpenetrating network.
Statistical differences are marked for p < 0.001.
Fig. 3 (A) Confocal microscopy images showing the reorganization of
HA (green) by the encapsulated MKN45 cells for different culture
times (bottom images, green corresponds to HA-FITC incorporated in
the Alg core; top images show the merged channels from the trans-
mitted and fluorescence images of the Alg/HA-FITC). (B) Young’s
modulus of Alg and Alg-HAMw hydrogels (core) in the presence
of encapsulated MKN45 cells. Statistical differences are marked for
p < 0.001.
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The use of Alg to generate the 3D polymer network
(through crosslinking with Ca2+) is compatible with cell
culture conditions.37 In addition, Alg also lacks adhesive epi-
topes and, thus, can serve as a bioinert background that allows
the evaluation of the bioactivity of the added HA. Such an
approach is advantageous because HA can be immobilized in
the 3D construct without any modification. The core contain-
ing HA was loaded with CCs (mimicking the cancer site),
which were embedded in a hydrogel disc, to which healthy
bmMSCs were encapsulated (mimicking the surrounding
environment). Moreover, the proposed core–shell model,
where CCs are confined in the hydrogel’s core, mimic the
hypoxic tumor physiological conditions and reduced flow of
nutrients.38 This system was used to evaluate the impact of
HA’s Mw on cancer invasiveness and the influence of the sur-
rounding healthy cells.
The viability of the cancer (i.e. MKN45) and healthy (i.e.
bmMSCs) cells, cultured on the developed 3D system, was
evaluated after 10 days of cell culture. Our Live/Dead stain-
ing results show high viability of both cell types in the core
and shell of the 3D system (Fig. 4A, S2† – split channels).
The formation of MKN45 cell clusters is visible in the core
of the hydrogel, with increased cell death in the Alg-only
sphere. The addition of HA into the core improves cellular
viability, which could be related to the internalization of HA
by the MKN45 cells, as suggested by the fluorescence
images obtained using HA-FITC (Fig. 3A, days 1 and 7).37
Moreover, the MKN45 cells seeded on HA of 6.4 kDa present
higher metabolic activity when compared to the hydrogels
presenting HA of higher Mw, showing the ability of the HA
Mw to modulate the proliferation and viability of cells
(Fig. 4B).
Cancer cell invasion and protein expression in the presence of
mesenchymal stem cells
The influence of MSCs on CC behavior is mediated through
the release of pro-inflammatory cytokines and/or growth
factors (e.g. TGF-beta1, VEGF and IL-6).39 However, direct
MSC-CC contact can also occur and lead to the disruption of
CC agglomerates mainly through the cleavage of the cell–cell
junctions, which are maintained by E-cadherin.15,40 The pres-
ence of MSCs in the TME also increases the sensitivity of CCs
to anti-cancer drugs.41 The MSC : CC ratio is also critical for
any outcome, including changes in CC invasiveness and tumor
progression.18,26
To mimic the complexity of the TME, we encapsulated
MSCs in the shell of the construct, which was designed to be
in direct contact with the core (representing the cancer site)
containing the encapsulated CCs. To track the movement of
each cell type, we tagged cells for the mesenchymal stem cell
marker, CD90,42 and the transmembrane HA receptor, CD44,
in all studied cells.43 Both cell types express CD90 and CD44
(Fig. S3†), but the relative expression is very different and can
be used to distinguish MKN45 cells from bmMSCs. Our results
show that MKN45 cells (encapsulated in the Alg-HA6.4 core)
escape into the Alg shell. When the core contained longer HA
chains (i.e. 741 and 1500 kDa), no MKN45 invasion was
observed but bmMSCs migrated from the shell into the core of
the construct (Fig. 5A and S4†).
In the TME, the secretion of pro-inflammatory cytokine
Interleukin-6 (IL-6) is linked to tumorigenesis, cancer cell pro-
liferation and metastasis.44 Herein, we observed a significant
increase of the IL-6 protein level in the medium from the co-
cultures of the core–shell hydrogels containing Alg-HA6.4
(Fig. 6). This is in good agreement with the migration pattern
of MKN45 cells, which showed an invasive character in the
presence of HA of low Mw. The absence of IL-6 expression on
MKN45 monoculture (Fig. S7†), as previously observed by
others,45 shows that bmMSCs in the tumour vicinity trigger
the aggressive character of the gastric CCs, which may be cor-
related with poor prognosis of cancer and resistance to
chemotherapy.45
The invasion of MKN45 cells from the Alg-HA6.4 core into
the shell was also observed in the absence of bmMSCs
(Fig. 5A; monoculture, white arrows) and this can be associ-
ated with (1) fast solubilization of the core structure, through
Fig. 4 (A) Live/Dead staining of co-cultures of MKN45 cells (in the
core, i.e. inside the circle marked by a dashed line) and bmMSCs (in the
shell, i.e. outside the circle) after 10 days of culture. Scale bars corres-
pond to 200 μm. Lower images correspond to the viability of the MKN45
cells’ clusters present inside the core (higher magnification). Scale bars
correspond to 50 μm. (B) Metabolic activity of MKN45 cells in the pres-
ence of MSCs (core–shell hydrogel). Statistical differences are marked
*** for p < 0.001 and ** for p < 0.01.
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the release of Ca2+ cations (as previously shown in Fig. 1 and
2), which leads to the reorganization of the core matrix
increasing the invasion of MKN45 cells; (2) the HA gradient
generated upon the diffusion of HA into the shell (Fig. 1B)
acting as directional cues for CC migration; and (3) the intern-
alization of HA6.4 by CCs, as suggested by the fluorescence
images of HA-FITC on the CC sites (core, Fig. 3A) which could
act as a signaling mechanism to induce CCs’ invasion.38,46
bmMSCs cultured alone did not migrate from the shell to the
HA-rich core (Fig. S4†); however, in the presence of MKN45
cells, it appears that the stem cells colonized Alg-HA1500
(Fig. 5A). The observed result (high relative intensity of green
in the core, Fig. 5A and B) can be also due to increased CD90
expression by MKN45 in the presence of bmMSCs in the vicin-
ity of the CCs. The same variation of CD90 expression was
observed for the MKN45 cell cultures supplemented with
medium from bmMSC expansion (Fig. S6†). This result
showed that MSC-secretome alone is able to modulate MKN45
behavior but the direct MSC–MKN45 contact amplifies this
response.
Disruption of MKN45 cell–cell contacts in the presence of
MSCs
The ability of bmMSCs to modulate the cell-to-cell contact in
tumors was assessed from the capacity of MKN45 cells to form
aggregates when cultured alone or together with bmMSCs
(Fig. 7). We observed significantly smaller MKN45 aggregates
in Alg and Alg-HA1500 in the presence of bmMSCs (Fig. 7B). We
believe that the co-culture on an Alg-only system induces a
faster degradation of the hydrogel, compromising cellular
adhesion and proliferation. On the other hand, bmMSCs cul-
tured in the shell of the Alg-HA1500 rich-core system promote
the formation of smaller CC aggregates and therefore inhibit
tumor growth. In fact, it has been previously reported that theFig. 5 (A) Invasion of MKN45 cells (mono- and co-culture) into the
shell and recruitment of bmMSCs (co-culture) into the core. (B and C)
Relative fluorescence intensity (normalised to Alg construct under
monoculture conditions) measured for the cells’ agglomerates in the
core that were immunolabelled for (B) CD90 and (C) CD44. Scale bars
correspond to 200 μm. Statistical differences are marked **** for p <
0.0001.
Fig. 6 IL-6 secretion measured by ELISA from the cells seeded in the
hydrogels under co-culture conditions. Statistical differences are
marked * for p < 0.05.
Fig. 7 Influence of the bmMSCs (cultured in the shells of the hydrogels)
on the aggregation of MKN45 cells in the core of the construct: (A) con-
focal microscopy images of MKN45 cells cultured alone (monoculture)
and together with bmMSCs (co-culture) and immunostained with DAPI
(cell nuclei). (B) Volume analysis of the CCs’ aggregates generated under
different cell culture conditions. Scale bars correspond to 200 μm.
Statistical differences are marked **** for p < 0.0001.
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same tumor inhibition occurred when a small, but relevant,
number of MSCs (a CC :MSCs ratio of 2 : 1) were injected into
the tumor site.47
The mesenchymal/epithelial markers expressed by the
MKN45 cells encapsulated in the core of the construct was
evaluated by western blotting (WB, Fig. 8). Under co-culture
conditions, the cells in the core enhance the expression of
vimentin, a mesenchymal marker42 for the Alg, Alg-HA741 and
Alg-HA1500 hydrogels’ cores. It is noteworthy that vimentin was
not expressed by MKN45 cells cultured alone or supplemented
with bmMSC-conditioned media (Fig. S8†). This observation is
consistent with the idea that either vimentin is derived from
the epithelial to mesenchymal transition of the MKN45 cells
or the bmMSCs attracted to the core are the source of this
vimentin expression. Overall, our results are consistent with
the latter possibility as bmMSCs are observed in the core of
the hydrogel formulated with HA of higher Mw (Fig. 5A).
Moreover, the presence of HA of high Mw has been reported to
induce CCs to produce chemotactic factors, such as cytokines
and growth factors, which act as chemoattractants for MSCs,
further supporting our results that show the recruitment of
bmMSCs to the core of the 3D system.48–50
For the same samples (i.e. Alg, Alg-HA741 and Alg-HA1500)
we also observed overexpression of E-cadherin by the cells in
the core of the 3D system showing an increment of the cell–
cell contacts. This result indicates the promotion of the epi-
thelial transition of MKN45 cells when they are in contact with
bmMSCs. The absence of vimentin expression and a downre-
gulation of E-cadherin (responsible for the epithelial cell–cell
junctions) in the MKN45 cells encapsulated in the Alg-HA6.4
core suggest that the CCs are not in direct contact with MSCs
in the core of the hydrogel, but instead CC invasion into the
shell is induced (loss of E-cadherin expression), as previously
reported.51
Conclusions
We developed a 3D core–shell model that is able to recapitu-
late a series of mechanical, biochemical and biological fea-
tures of a gastric TME. Using co-culturing conditions (MKN45
cells at the tumour site and bmMSCs in its periphery) we
were able to mimic the influence of healthy bmMSCs on the
CCs’ behavior. We further demonstrate that the HA’s Mw at
the cancer site is able to modulate CCs’ behavior. Low Mw
HA, e.g. HA6.4, induces a migratory phenotype in MKN45
cells, which also internalize HA immediately after cell
seeding. In contrast, HA of high Mw, e.g. HA1500, does not
promote an invasive behavior on MKN45 CCs; instead, it
attracts bmMSCs to the cancer site, reducing the growth of
CC clusters. Overall, with the developed core–shell 3D model,
we were able to mimic the TME and assess the influence of
the biochemical features of specific components of the
cancer ECM, e.g. HA and its Mw, as well as the presence of
bmMSCs, on CCs’ behaviour.
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Fig. 8 (A) Western blot analysis of E-cadherin (120 kDa), vimentin
(55 kDa) and smooth muscle actin (αSMA – 40 kDa) as the loading
control, from the cells’ protein lysates present in the core of the hydro-
gel. The values represent the densitometric intensity normalized to
αSMA. (B) Graphical presentation of the effect of the HA size on the cel-
lular response of MKN45 (red) cells and bmMSCs (green).
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